Search results
Showing 31 to 45 of 72 results for diabetic foot
Diabetes (type 1 and type 2) in children and young people: diagnosis and management (NG18)
This guideline covers the diagnosis and management of type 1 and type 2 diabetes in children and young people aged under 18. The guideline recommends how to support children and young people and their families and carers to maintain tight control of blood glucose to reduce the long-term risks associated with diabetes.
NICE has developed a medtech innovation briefing (MIB) on MolecuLight i:X for wound imaging .
This indicator covers the proportion of children and young people with diabetes who have a record of a foot examination in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG73
This indicator covers the percentage of patients with diabetes with a record of a foot examination and risk classification: 1) low risk (normal sensation, palpable pulses), 2) increased risk (neuropathy or absent pulses), 3) high risk (neuropathy or absent pulses plus deformity or skin changes or previous ulcer) or 4) ulcerated foot within the preceding 15 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM13
This indicator covers the percentage of patients with diabetes with a record of testing of foot sensation using a 10 g monofilament within the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM131
NICE guidance that could generate cost savings.
Introduction of a new leg ulcer pathway and Urgostart dressings for venous leg ulcers in Manchester
UrgoStart for treating diabetic foot ulcers and leg ulcers (MTG42)
This indicator covers the percentage of patients with diabetes who have had the following care processes performed in the preceding 12 months: BMI measurement, BP measurement, HbA1c measurement, cholesterol measurement, record of smoking status, foot examination, albumin:creatinine ratio, eGFR creatinine measurement. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM74
This indicator covers the proportion of adults with diabetes who have received all 9 basic care processes. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG13
NG19/2 Question Referral criteria for the foot protection service and the multidisciplinary foot care service:- When and...
Discontinued [GID-TAG371]
NICE has developed a medtech innovation briefing (MIB) on WoundExpress to manage lower leg wounds .
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.
criteria should people with diabetes be referred to the foot protection service or the multidisciplinary foot care service?...
criteria should people with diabetes be referred to the foot protection service or the multidisciplinary foot care service?...